Bausch Health (NYSE:BHC) shares added ~4% on Friday after John Paulson, a board member of the Canadian pharma giant, disclosed the purchase of more than $300M worth of company shares. Bausch + Lomb (BLCO), a Bausch Health (NYSE:BHC) subsidiary in which Paulson holds another board position, also traded higher.
According to a regulatory filing on Thursday, Paulson, the President and Portfolio Manager of Paulson Capital, bought more than 34.7M shares of Bausch Health (NYSE:BHC) stock for an average of $9.00 apiece in a transaction worth roughly $312.5M.
The transaction conducted on Thursday has lifted Paulson’s stake in the eye care company by 96%. A day earlier, he had purchased about 3.2M BHC shares for an average price of approximately $6.56 apiece in a deal valued at $21.3M.
Meanwhile, according to an amended 13-D filing, billionaire investor Carl Icahn has liquidated his entire stake in Bausch Health (BHC) with a sale of nearly 34.7M BHC shares on Thursday.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.